AntonyJMDeslauriersAMBhatRK. Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?Biochim Biophys Acta2011; 1812: 162–176.
2.
HughesJFCoffinJM. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet2001; 29: 487–489.
3.
StoyeJP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol2012; 10: 395–406.
4.
BlondJLLavilletteDCheynetV. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol2000; 74: 3321–3329.
5.
PerronHGermiRBernardC. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. Epub ahead of print 30March2012.
6.
GarsonJATukePWGiraudP. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet1998; 351: 33.
7.
SerraCSotgiuSMameliG. Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci2001; 22: 171–173.
8.
SotgiuSSerraCMameliG. Multiple sclerosis-associated retrovirus and MS prognosis: An observational study. Neurology2002; 59: 1071–1073.
9.
PerronHJouvin-MarcheEMichelM. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology2001; 287: 321–332.
10.
AntonyJMEllestadKKHammondR. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: A role for endoplasmic reticulum chaperones in astrocytes. J Immunol2007; 179: 1210–1224.
11.
ChristensenT. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol2005; 15: 179–211.
12.
GiovannoniG. Epstein-Barr Virus and MS. Int MS J2011; 17: 44–49.
13.
GiovannoniGCutterGRLunemannJ. Infectious causes of multiple sclerosis. Lancet Neurol2006; 5: 887–894.
14.
CurtinFLangABPerronH. Safety and pharmacokinetics of GNbAC1, a humanised monoclonal antibody against the multiple sclerosis retrovirus envelope protein. J Mult Scler2012; 28th meeting of the European Committee for Treatment and Research in Multiple Sclerosis, Lyon, France, 10–13 October 2012, P558.
15.
HillAB. The environment and disease: Association or causation?Proc R Soc Med1965; 58: 295–300.
